Here are the 424B prospectus supplements from Babcock & Wilcox Enterprises, Inc. 8.125% Senior Notes due 2026 (BWSN) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow BWSN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BWSN filings page.
Babcock & Wilcox Enterprises, Inc. is offering 10,810,811 shares of Common Stock. The prospectus supplement describes a firm-commitment underwritten offering at a public offering price of $18.50 per share with gross proceeds of approximately $200.0 million and an underwriter option to purchase up to an additional 1,621,621 shares for 30 days.
The company expects to use net proceeds to prepay amounts under its Credit Agreement (subject to lender requirements), and to reborrow for project-related capital, BrightLoop commercialization, AI data center projects, potential acquisitions, and general corporate purposes. The offering will increase shares outstanding to 147,023,312 (or 148,644,933 if the option is exercised).
Babcock & Wilcox Enterprises, Inc. is offering shares of its Common Stock in an underwritten public offering under a preliminary prospectus supplement. The offering is being underwritten on a firm commitment basis with a 30-day option for additional shares.
Proceeds are required to be applied to prepay amounts outstanding under the Company’s Credit Agreement and the Company states it would intend to reborrow such amounts to fund project-related capital, working capital, growth initiatives including AI data center projects and BrightLoop commercialization, potential acquisitions, and general corporate purposes. The Company reported 136,212,501 shares outstanding as of May 6, 2026, had approximately $58.2 million available under an at-the-market program as of May 12, 2026, and reported a pipeline of over $14.0 billion with a BrightLoop™ pipeline of more than $2.3 billion. The prospectus supplement discloses material credit metrics and contingencies, including an up to $150.0 million asset-based Credit Facility and approximately $37.9 million outstanding under the Credit Agreement as of March 31, 2026.